COVINGTON, LOUISIANA, October 3, 2019 –MitoCarn will launch its suite of patented L-Carnitine solutions at SupplySide West next month. SupplySide attendees will be among the first to preview its four targeted L-‐Carnitine ingredients, including MitoCarn™ Brain, MitoCarn™ Heart, MitoCarn™ Sport, and MitoCarn™ Weight at booth #5936 at the Mandalay Bay in Las Vegas, Nevada on October 17-‐18, 2019.
MitoCarn’s™ L-‐Carnitine solutions focus on optimizing mitochondrial function by providing continuous energy to the body, antioxidant protection for cells, supporting lean energy production, minimizing cellular waste during ATP, and helping to manage the cellular aging process*. MitoCarn’s™ targeted ingredients are uniquely designed to address four primary functions:
- MitoCarn™ Heart: provides extra energy to heart cells during the metabolic process and helps increase blood flow to the heart and muscles.
- MitoCarn™ Brain: is an Acetyl L-‐Carnitine compound that helps provide brain cells with the fuel they need to support healthy memory, learning, recall, and cognition levels.
- MitoCarn™ Sport: is an L-‐Carnitine and fumaric acid compound that helps pumps up workouts, improves endurance and stamina, and renews fatigued muscles.
- MitoCarn™ Weight: optimizes healthy metabolic function and increases insulin sensitivity for easier weight management.
“Mitochondrial function has taken on great importance as a primary contributor to overall health,” said Vaughn DuBow, Brand Manager for MitoCarn™. “There has been significant advancement in research related to cellular and molecular contributors to the overall aging process. With the development of MitoCarn™, we really sought out to provide consumers with the most tested, proven and effective forms of L-‐Carnitine to address mitochondrial health. We’re really excited to share these solutions with SupplySide West attendees.” MitoCarn™ ingredients offer superior quality assurance and traceability. The ingredients are produced in Biosint’s S.p.A. pharmaceutical facility in Semoneta, Italy, which is recognized as the first manufacturer of L-‐Carnitine to obtain FDA approval. In addition, MitoCarn™ is backed by 31 process patents and over 100 clinical studies for safety and function. A Certificate of Analysis confirming test methods and declarations showing the absence of toxins, pesticides, allergens, GMO, irradiation, and nanomaterials accompanies every batch produced.
For more information on MitoCarn™ or its suite of patented L-‐Carnitine ingredients, visit SupplySide booth #5936 or MitoCarn.com.
About MitoCarn™
MitoCarn™ offers four targeted L-‐Carnitine ingredients, MitoCarn™ Brain, MitoCarn™ Heart, MitoCarn™ Sport, and MitoCarn™ Weight, which focus on optimizing mitochondrial function by providing continuous energy to the body, antioxidant protection for cells, supporting lean energy production, minimizing cellular waste during ATP, and helping to manage the cellular aging process*. Backed by 31 process patents and over 100 clinical studies for safety and function, MitoCarn™ provides a long-‐standing commitment to providing exceptional quality ingredients. MitoCarn™ is produced in Biosint’s S.p.A. pharmaceutical facility in Semoneta, Italy. Biosint is recognized as the first manufacturer of L-‐Carnitine to obtain FDA approval. For more information, visit MitoCarn.com.
MitoCarn™ offers four targeted L-‐Carnitine ingredients, MitoCarn™ Brain, MitoCarn™ Heart, MitoCarn™ Sport, and MitoCarn™ Weight, which focus on optimizing mitochondrial function by providing continuous energy to the body, antioxidant protection for cells, supporting lean energy production, minimizing cellular waste during ATP, and helping to manage the cellular aging process*. Backed by 31 process patents and over 100 clinical studies for safety and function, MitoCarn™ provides a long-‐standing commitment to providing exceptional quality ingredients. MitoCarn™ is produced in Biosint’s S.p.A. pharmaceutical facility in Semoneta, Italy. Biosint is recognized as the first manufacturer of L-‐Carnitine to obtain FDA approval. For more information, visit MitoCarn.com.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.